Nova Patents
IL253965B

Sublingual apomorphine

Abstract

This record has no abstract on file.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Published
  4. Today

88 members in 21 offices

This recordMember, by publication datePriority claim11 more offices are in the list below

Priority claims3

Priority claims
DocumentOfficeKindDate
61186445United States of America–
18644509United States of AmericaP
2010038336United States of AmericaW

Members88

Family members, oldest first
DocumentOfficeKind
CA2765291A1CanadaA1
WO2010144817A1World Intellectual Property Organization (WIPO)A1
US2011111011A1United States of AmericaA1
AU2010259971A1AustraliaA1
MX2011013260AMexicoA
IL216923A0IsraelA0
IL216923D0IsraelD0
EP2442650A1European Patent Office (EPO)A1
KR20120042836ARepublic of KoreaA
CN102480958AChinaA
EA201270012A1Eurasian Patent Organization (EAPO)A1
EP2442650A4European Patent Office (EPO)A4
JP2012530066AJapanA
HK1171340AHong Kong, ChinaA
HK1171340A1Hong Kong, ChinaA1
ZA201109208BSouth AfricaB
NZ597237ANew ZealandA
US9044475B2United States of AmericaB2
JP5760295B2JapanB2
US2015216859A1United States of AmericaA1
CN102480958BChinaB
KR20150094648ARepublic of KoreaA
EP2442650B1European Patent Office (EPO)B1
JP2015199743AJapanA
DK2442650T3DenmarkT3
EP2952191A1European Patent Office (EPO)A1
PT2442650EPortugalE
ES2554626T3SpainT3
PL2442650T3PolandT3
CA2765291CCanadaC
US2016081914A1United States of AmericaA1
US2016089328A1United States of AmericaA1
US2016089367A1United States of AmericaA1
US2016095851A1United States of AmericaA1
US2016101101A1United States of AmericaA1
US9326981B2United States of AmericaB2
JP2016147882AJapanA
AU2010259971B2AustraliaB2
BR112012000204A2BrazilA2
HUE028121T2HungaryT2
EA025054B1Eurasian Patent Organization (EAPO)B1
AU2010259971C1AustraliaC1
AU2017200329A1AustraliaA1
HK1218630AHong Kong, ChinaA
HK1218630A1Hong Kong, ChinaA1
KR20170027711ARepublic of KoreaA
US9669018B2United States of AmericaB2
US9669019B2United States of AmericaB2
US9669020B2United States of AmericaB2
US9669021B2United States of AmericaB2
JP6141354B2JapanB2
IL216923AIsraelA
IL253965A0IsraelA0
IL253965D0IsraelD0
JP6267254B2JapanB2
JP2018083820AJapanA
BR112012000204A8BrazilA8
KR20180069100ARepublic of KoreaA
EP2952191B1European Patent Office (EPO)B1
US2018289699A1United States of AmericaA1
AU2017200329B2AustraliaB2
PT2952191TPortugalT
DK2952191T3DenmarkT3
EP3434270A1European Patent Office (EPO)A1
AU2019200308A1AustraliaA1
ES2699077T3SpainT3
PL2952191T3PolandT3
JP6506381B2JapanB2
JP2019123732AJapanA
KR102017009B1Republic of KoreaB1
KR20190103472ARepublic of KoreaA
US10420763B2United States of AmericaB2
US2020030315A1United States of AmericaA1
KR102086311B1Republic of KoreaB1
JP6770126B2JapanB2
BR112012000204B1BrazilB1
AU2019200308B2AustraliaB2
JP2021001209AJapanA
AU2021201259A1AustraliaA1
BR112012000204B8BrazilB8
US2021322403A1United States of AmericaA1
IL253965AIsraelA
IL253965BThis recordIsraelB
EP2442650B2European Patent Office (EPO)B2
FI2442650T4FinlandT4
DK2442650T4DenmarkT4
PL2442650T5PolandT5
ES2554626T5SpainT5